Ellie Baker recently joined Purdie Pascoe as PMCF Commercial Director. In this interview, Ellie shares why medical device manufacturers consider PMCF surveys, how she helps guide clients through the complexities of the MedTech landscape and how her first few weeks have been at the business.

Post-Market Clinical Follow-up (PMCF) surveys can help address clinical data gaps that may impact the ongoing assessment of a medical device’s safety and performance. Unearthing clinical gaps requires a systematic approach, including a review of clinical literature, post-market surveillance data, and regulatory compliance standards.

The Purdie Pascoe Post Market Clinical Follow-up (PMCF) team was out in full force at this this year’s Regulatory Affairs Professionals Society (RAPS) convergence in Brussels. Marcus Torr, PMCF/MDR Lead, attended with newly appointed PMCF Commercial Director, Ellie Baker and PMCF Managers, Chris Webb and Tonika Chester.

As Senior PMCF Medical Writer at Purdie Pascoe, Priyal Sharma offers her perspective about the benefits of having an in-house medical writer at an insights agency, how she ensures accuracy and clarity when communicating complex medical information and how she collaborates with the wider PMCF team.

We are delighted to announce that Ellie Baker has joined Purdie Pascoe’s Post Market Clinical Follow-Up Survey division as Commercial Director. Ellie brings over a decade of experience in healthcare market research, strategy, and business development, with a strong focus on MedTech and Pharma.

We are delighted to be the exhibiting and presenting at the RAPS Euro Convergence, 13-16 May 2025 in Brussels. Purdie Pascoe’s PMCF experts, Marcus Torr, Chris Webb and Tonika Chester are attending, presenting a poster and exhibiting on Booth 37.

PMCF experts Chris Webb and Alice Robertson recently attended and presented at the 6th Annual European Medical Device and Diagnostic Clinical Evidence Strategy Conference in Berlin. This event brought together leading clinical experts and industry professionals to discuss key issues in advancing clinical evidence.

In the third blog of our PMCF Insights Series, PMCF Manager Chris Webb, highlights why it is imperative for manufacturers to provide clinical evidence to show their devices perform as expected over its entire lifetime, as specified within the Device Regulation (EU-MDR 2017/745).

Post-market clinical follow-up (PMCF) surveys have become a significant topic in the industry, offering a cost-effective solution for PMCF data collection. However, their effective implementation can be challenging. In this article, the PMCF experts at Purdie Pascoe focus on high-quality, case/patient-specific PMCF surveys that provide Level 4 data.

We are delighted to be the platinum sponsor for the 6th Annual European Medical Device and Diagnostic Clinical Evidence Strategy Conference in Berlin. PMCF Managers Chris Webb and Alice Robertson will be attending and presenting at the conference.

Watch this complimentary webcast in which PMCF Manager from Purdie Pascoe, Chris Webb, presented with Dr. Ulrich Nitsche Global Director Clinical Centre of Excellence from TÜV SÜD and Dr. Nikhil A. Khadabadi from Eclevar MedTech. These leading experts unpack critical PMCF strategies, share real-world survey experiences, and offer insights on bridging data gaps to achieve regulatory success.

In the second blog of our PMCF Insights Series, Tonika Chester and Isabel Bradshaw explore off-label usage within medical devices, from collecting off-label data in post market clinical follow up, understanding and key considerations for off-label usages to the challenges in paediatric populations and rare diseases.

A leading medical device manufacturer required Post Market Clinical Follow-Up (PMCF) data for their Class III Peripherally Inserted Central Catheter (PICC). This clinical evidence was needed to comply with PMCF data collection under the MDR

We are thrilled to announce that Marcus Torr, PMCF/MDR Lead at Purdie Pascoe, has been selected for the MedTech Leading Voice (MLV) list for 2025. Marcus regularly shares his expertise at industry events and on LinkedIn. We are incredibly proud to see him featured in the prestigious MLV100 list. Don't miss his future insights by following him on LinkedIn.

In the first blog of our PMCF Insights Series, Hemant Mistry and Matthew Hanson explore different types of bias in medical device research, the measures being taken to address these issues, and how Purdie Pascoe's deep expertise helps eliminate bias in PMCF surveys.

Lindsey Cotterill provides her perspective about the importance of a robust operations and compliance function to ensure seamless execution of primary market research projects and PMCF surveys. She delves into key compliance regulations, strategies to ensure security and confidentiality of data and how each Purdie Pascoe employee is diligently trained about compliance issues and best practices.

A leading medical device manufacturer required Post Market Clinical Follow-Up (PMCF) data for their legacy Class I syringe. This clinical evidence was needed to comply with PMCF data collection under the EU-MDR. Find out how our PMRC survey approach strengthened the regulatory compliance for their device.

Marcus Torr provides about his perspective about the importance of PMCF Survey implementation for medical device EU-MDR submissions. He reveals why medical device manufacturers should consider PMCF surveys, how to overcome challenges, solutions for a best practice approach and what makes Purdie Pascoe’s specialist expertise unique.

Purdie Pascoe Post Market Clinical Follow-up (PMCF) Survey experts, Marcus Torr and Chris Webb recently attended the RAPS European Clinical, Risk and Postmarket Surveillance Conference in Barcelona, Spain.

Whether you're new to PMCF or looking to refine your approach, this webcast is designed to provide actionable insights to help you achieve success in your PMCF activities, stay ahead of the curve and ensure your medical devices meet the highest standards of safety and performance.